Spontaneous hyperplasia of the ventral lobe of the prostate in aging genetically hypertensive rats

Journal of Andrology

Volumn 21, Issue 1, 2000, Pages 58-64

  Golomb, Eliahu ^b   Rosenzweig, Nurit ^c   Eilam, Raya ^a   Abramovici, Armand ^c  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c NONE

Author keywords

Blood pressure; Prostatitis; Senescent rats; Sympathetic nervous system

Indexed keywords

ADRENERGIC SYSTEM; AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; HISTOPATHOLOGY; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROSTATE VENTRAL LOBE; RAT; RAT STRAIN; SCORING SYSTEM;

AGING; ANIMALS; HYPERTENSION; MALE; PROSTATIC HYPERPLASIA; RATS; RATS, INBRED SHR; RATS, INBRED WKY;

EID: 0033983539     PISSN: 01963635     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Aguilar E, Rodriguez Padilla ML, Bellido C, Tena-Sempere M, Pinilla L. Changes in follicle-stimulating hormone secretion in spontaneously hypertensive rats. Neuroendocrinology. 1992;56:85-93.
2. Andersson KE. Prostatic and extraprostatic α-adrenoceptors - contributions to the lower urinary tract symptoms in benign prostatic hyperplasia. Scand J Urol Nephrol (Suppl). 1996;179:105-111.
3. Baumgarten HG, Falck B, Holstein AF, Owman C, Owman T. Adrenergic innervation of the human testis, epididymis, ductus deferens and prostate: a fluorescence microscopic and fluorimetric study. Z Zellforsch Mikrosk Anat. 1968;90:81-95.
4. Beduschi MC, Beduschi R, Oesterling JE. Alpha-blockade therapy for benign prostatic hyperplasia: from a nonselective to a more selective alpha 1A-adrenergic antagonist. Urology. 1998;51:861-872.
5. Boyle P. Epidemiology of benign prostatic hyperplasia: risk factors and concomitance with hypertension. Br J Clin Pract (Suppl). 1994;74: 18-22.
6. Caine M. Clinical experience with α-adrenoceptor antagonists in benign prostatic hyperplasia. Fed Proc: 1986;45:2604-2608.
7. Caine M. Reflections on α-blockade therapy for benign prostatic hyperplasia. Br J Urol. 1995;75:265-270.
8. Clemow DB, McCarty R, Steers WD, Tuttle JB. Efferent and afferent neuronal hypertrophy associated with micturition pathways in spontaneously hypertensive rats. Neurourol Urodyn. 1997;16:293-303.
9. Clemow DB, Steers WD, McCarty R, Tuttle JB. Altered regulation of bladder nerve growth factor and neurally mediated hyperactive voiding. Am J Physiol. 1998;275:1279-1286.
10. Clemow DB, Spitsbergen JM, McCarty R, Steers WD, Tuttle JB. Altered NGF regulation may link a genetic predisposition for hypertension with hyperactive voiding. J Urol. 1999;161:1372-1377.
11. Cunha GR. Role of mesenchymal-epithelial interactions in normal and abnormal development of mammary gland and prostate. Cancer (Suppl). 1994;74 (3 Suppl):1030-1044.
12. Eilam R, Malach R, Bergmann F, Segal M. Hypertension induced by hypothalamic transplantation from genetically hypertensive to normotensive rats. J Neurosci. 1991;11:401-411.
13. Elbadawi A, Goodmas DC. Autonomic innervation of accessory male genital glands. In: Spring-Mills E, Hafez SEE, eds. Male Accessory Sex Glands. Amsterdam, The Netherlands: Elsevier, North Holland Biomedical Press; 1980:101-128.
14. Frohlich ED. Left ventricular hypertrophy: dissociation of structural and functional effects by therapy. Adv Exp Med Biol. 1991;308:175-190.
15. Golomb E, Hill MR, Brown RG, Keiser HR. Ouabain enhances the mitogenic effect of serum in vascular smooth muscle cells. Am J Hypertens. 1994;7:69-74.
16. Golomb E, Kruglikova A, Dvir D, Parnes N, Abramovici A. Induction of atypical prostatic hyperplasia in rats by sympathomimetic stimulation. Prostate. 1998;34:214-221.
17. Guicheney P, Wauquier I, Paquet JL, Meyer P. Enhanced response to growth factors and to angiotensin II of spontaneously hypertensive rat skin fibroblasts in culture. J Hypertens. 1991;9:23-27.
18. Ho SM, Leav I, Merk FB, Yu M, Kwan PW, Ziar J. Induction of atypical hyperplasia, apoptosis, and type II estrogen-binding sites in the ventral prostates of Noble rats treated with testosterone and pharmacologic doses of estradiol-17β. Lab Invest. 1995;73:356-365.
19. Julius S. The evidence for a pathophysiologic significance of the sympathetic overactivity in hypertension. Clin Exp Hypertens. 1996;18: 305-321.
20. Kumai T, Tanaka M, Tateishi T, Watanabe M, Nakura H, Kobayashi S. Enhancement of the affinity of androgen receptor in the adrenal medulla of spontaneously hypertensive rats. Clin Exp Hypertens. 1997; 19:1179-1191.
21. Kyprianou N, Litvak JP, Borkowski A, Alexander R, Jacobs SC. Induction of prostate apoptosis by doxazosin in benign prostatic hyperplasia. J Urol. 1998;159:1810-1815.
22. Lepor H, Tang R, Meretyk S, Shapiro E. Binding and functional properties of alpha-1 adrenoreceptors in different regions of the human prostate. J. Urol. 1993;150:253-256.
23. Lillie RD. Histopathologic Techniques and Practical Histochemistry. New York: McGraw-Hill Inc; 1965.
24. Magee JC, Schofield GG. Alterations of synaptic transmission in sympathetic ganglia of spontaneously hypertensive rats. Am J Physiol. 1994;267:1397-1407.
25. Mancia G. The sympathetic nervous system in hypertension. J Hypertens. 1997;15:1553-1565.
26. Martinez-Piñeiro L, Dahiya R, Nuñez LL, Tanagho EA, Schmidt RA. Pelvic plexus denervation in rats causes morphologic and functional changes of the prostate. J Urol. 1993;150:215-218.
27. McVary KT, Razzaq A, Lee C, Venegas MF, Rademaker A, McKenna KE. Growth of the rat prostate gland is facilitated by the autonomic nervous system. Biol Reprod. 1994;51:99-107.
28. McVary KT, McKenna KE, Lee C. Prostate innervation. Prostate (Suppl). 1998;8:2-13.
29. Nakamura H, Sugimoto J, Kojima T, Kodama K, Takechi M, Itakura C. Morphological abnormality of the epithelium in the prostate gland of spontaneously hypertensive rats. J Toxicol Pathol. 1991;4:183-193.
30. Nakamura H, Itakura C. Influence of terazosin on the epithelium of prostate gland of spontaneously hypertensive rats. J Toxicol Pathol. 1992; 5:101-104.
31. Paquet JL, Baudouin-Legros M, Marche P, Meyer P. Enhanced proliferating activity of cultured smooth muscle cells from SHR. Am J Hypertens. 1989;2:108-110.
32. Persson K, Pandita RK, Spitsbergen JM, Steers WD, Tuttle JB, Andersson KE. Spinal and peripheral mechanisms contributing to hyperactive voiding in spontaneously hypertensive rats. Am J Physiol. 1998;275: 1366-1373.
33. Pool JD. Role of the sympathetic nervous system in hypertension and benign prostalic hyperplasia. Br J Clin Pract Symp (Suppl). 1994:74: 13-17.
34. Scolnik M, Servadio C, Abramovici A. Comparative study of experimentally induced benign and atypical hyperplasia in the ventral prostate of different rat strains. J Androl. 1994;15:287-292.
35. Teillac P. Relief of BPO or improvement in quality of life? Eur Urol (Supl 2). 1998;34:3-9.
36. Uchino K, Frohlich ED, Nishikimi T, Issmhiki T, Kardon MB. Spontaneously hypertensive rats demonstrate increased renal vascular aladrenergic receptor responsiveness. Am J Physiol. 1991;260:889-893.
37. Wang JM, McKenna KE, McVary KT, Lee CH. Requirement of innervation for the maintenance of structural and functional integrity in rat prostate. Biol Reprod. 1991;44:1171-1176.